In clear cell RCC, mutations in the von Hippel–Lindau gene, a tumor suppressor, are generally associated with decreased degradation of hypoxia-inducible factors, increased transcription of vascular endothelial growth factor (VEGF), and tumor-induced angiogenesis [3]. The gene discussed is VEGFA; the disease is neoplasm.